We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+3.92%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$62M
AUM Growth
+$2.53M
Cap. Flow
+$601K
Cap. Flow %
0.97%
Top 10 Hldgs %
17.86%
Holding
562
New
23
Increased
266
Reduced
152
Closed
30

Top Buys

Rank Stock Value
1
PFG icon
Principal Financial Group
PFG
+$1.05M
2
CVS icon
CVS Health
CVS
+$1.04M
3
MDT icon
Medtronic
MDT
+$916K
4
UPS icon
United Parcel Service
UPS
+$322K
5
NVS icon
Novartis
NVS
+$316K

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$881K
2
GE icon
GE Aerospace
GE
+$831K
3
LLY icon
Eli Lilly
LLY
+$639K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$373K
5
KSS icon
Kohl's
KSS
+$239K

Sector Composition

Rank Sector Weight
1 Technology 15.59%
2 Industrials 14.22%
3 Healthcare 13.42%
4 Financials 12.85%
5 Consumer Discretionary 12.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTBI icon
276
Community Trust Bancorp
CTBI
$1.41B
$10K 0.02%
203
CXW icon
277
CoreCivic
CXW
$3.26B
$10K 0.02%
414
-120
-22% -$2.29K
DECK icon
278
Deckers Outdoor
DECK
$13.3B
$10K 0.02%
1,038
+174
+20% +$1.68K
DLX icon
279
Deluxe
DLX
$1.12B
$10K 0.02%
145
+15
+12% +$1.01K
FCN icon
280
FTI Consulting
FCN
$4.17B
$10K 0.02%
225
+13
+6% +$565
IDXX icon
281
Idexx Laboratories
IDXX
$46.9B
$10K 0.02%
82
+9
+12% +$1.03K
KEX icon
282
Kirby Corp
KEX
$7B
$10K 0.02%
155
-5
-3% -$316
NDSN icon
283
Nordson
NDSN
$17.2B
$10K 0.02%
91
+5
+6% +$524
CLGX
284
DELISTED
Corelogic, Inc.
CLGX
$10K 0.02%
285
+73
+34% +$2.83K
BWLD
285
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$10K 0.02%
67
+7
+12% +$1.09K
CY
286
DELISTED
Cypress Semiconductor
CY
$10K 0.02%
907
+190
+26% +$2.08K
CRL icon
287
Charles River Laboratories
CRL
$13.2B
$9K 0.01%
117
+28
+31% +$2.13K
CRS icon
288
Carpenter Technology
CRS
$27.8B
$9K 0.01%
258
+24
+10% +$890
ENR icon
289
Energizer
ENR
$1.5B
$9K 0.01%
207
+38
+22% +$1.73K
GNTX icon
290
Gentex
GNTX
$5.02B
$9K 0.01%
465
+20
+4% +$364
INTC icon
291
Intel
INTC
$492B
$9K 0.01%
243
JACK icon
292
Jack in the Box
JACK
$340M
$9K 0.01%
81
+5
+7% +$511
MTX icon
293
Minerals Technologies
MTX
$2.32B
$9K 0.01%
121
NYT icon
294
New York Times
NYT
$10.5B
$9K 0.01%
651
+49
+8% +$606
PZZA icon
295
Papa John's
PZZA
$785M
$9K 0.01%
+107
New +$8.87K
ROL icon
296
Rollins
ROL
$17.9B
$9K 0.01%
592
+32
+6% +$444
SSO icon
297
ProShares Ultra S&P500
SSO
$8.41B
$9K 0.01%
952
+16
+2% +$145
SYNA icon
298
Synaptics
SYNA
$4.09B
$9K 0.01%
160
+20
+14% +$1.16K
TER icon
299
Teradyne
TER
$57.1B
$9K 0.01%
353
-10
-3% -$237
UTHR icon
300
United Therapeutics
UTHR
$22.7B
$9K 0.01%
66
+5
+8% +$638

Similar funds

Weaver C. Barksdale & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Weaver C. Barksdale & Associates held 562 positions worth $62M, up 4.2% from $59.5M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Weaver C. Barksdale & Associates's Q4 2016 filing shows 23 new, 266 increased, 152 reduced and 30 closed positions. Its largest new stake was Principal Financial Group: 18,823 shares worth $1.09M. The largest sale was Coca-Cola, an estimated $881K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.

  • Weaver C. Barksdale & Associates's largest Q4 2016 buy was Principal Financial Group: 18,823 shares worth $1.09M.
  • Weaver C. Barksdale & Associates added most to United Parcel Service in Q4 2016, an estimated $322K increase.
  • Weaver C. Barksdale & Associates's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $639K.
  • Weaver C. Barksdale & Associates fully exited Coca-Cola in Q4 2016, selling an estimated $881K.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 18% of its $62M portfolio in Q4 2016.
  • Weaver C. Barksdale & Associates opened 23 new positions and closed 30 in Q4 2016.
  • Weaver C. Barksdale & Associates's portfolio value rose 4.2% quarter-over-quarter to $62M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.